Scholarlink

<p>This review aimed to assess the efficacy of probiotics on clinical parameters in smoking patients with periodontal diseases. An electronic search was carried out, without date or language restrictions, in the PubMed, Web of Science, Embase, and Scopus databases for identification of clinical trials whose population consisted of smokers with gingivitis or periodontitis, undergoing probiotic therapy associated to non-surgical periodontal therapy, and that carried out evaluation of periodontal clinical parameters. The risk of bias was assessed using the Joanna Briggs Institute Critical Assessment Checklist. Among the 162 studies identified, four were eligible for qualitative synthesis. Eight probiotic species were identified, predominantly Lactobacilli, with <i>L. reuteri</i> being the most prevalent. These probiotics were administered in tablet or lozenge form. Probiotics, in combination with non-surgical periodontal therapy, demonstrated reductions in gingival index, probing pocket depth, and bleeding on probing. Furthermore, probiotics exhibited efficacy comparable to antibiotics in grade C periodontitis treatment. Risk of bias was deemed low across all studies. Within the limitations of this review, it can be concluded that probiotic therapy appears to confer benefits to non-surgical periodontal therapy in smoking patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Does Probiotic Therapy Improve Periodontal Treatment Outcomes in Smoking Patients? A Systematic Review of Randomized Clinical Trials

  • 期刊论文

  • 发表日期：

    2025年8月16日

查看全文
  • Agnes Andrade Martins,
  • Luanny de Brito Avelino Cassiano,
  • Francisco Leonardo Silva Júnior,
  • Sergei Godeiro Fernandes Rabelo Caldas,
  • Ruthineia Diógenes Alves Uchôa Lins,
  • Ana Rafaela Luz de Aquino Martins

摘要

This review aimed to assess the efficacy of probiotics on clinical parameters in smoking patients with periodontal diseases. An electronic search was carried out, without date or language restrictions, in the PubMed, Web of Science, Embase, and Scopus databases for identification of clinical trials whose population consisted of smokers with gingivitis or periodontitis, undergoing probiotic therapy associated to non-surgical periodontal therapy, and that carried out evaluation of periodontal clinical parameters. The risk of bias was assessed using the Joanna Briggs Institute Critical Assessment Checklist. Among the 162 studies identified, four were eligible for qualitative synthesis. Eight probiotic species were identified, predominantly Lactobacilli, with L. reuteri being the most prevalent. These probiotics were administered in tablet or lozenge form. Probiotics, in combination with non-surgical periodontal therapy, demonstrated reductions in gingival index, probing pocket depth, and bleeding on probing. Furthermore, probiotics exhibited efficacy comparable to antibiotics in grade C periodontitis treatment. Risk of bias was deemed low across all studies. Within the limitations of this review, it can be concluded that probiotic therapy appears to confer benefits to non-surgical periodontal therapy in smoking patients.